Genelux (GNLX) EBITDA Margin (2022 - 2024)
Genelux (GNLX) posted quarterly EBITDA Margin of 101437.5% for Q1 2024, down 9763632.0% year-over-year from N/an in Q2 2023, and down 2568.58% quarter-over-quarter from 3801.18% in Q1 2023.
Genelux (GNLX) EBITDA Margin (2022 - 2024) Analysis & Trends
Genelux's EBITDA Margin history runs 3 years deep, the most recent figure standing at 101437.5% for Q1 2024.
- In Q1 2024, EBITDA Margin fell 9763632.0% year-over-year to 101437.5%; the TTM figure through Dec 2024 stood at 396200.0% (down 38198529.0% YoY), while the FY2025 annual figure was 415175.0%, down 1897500.0% from the prior year.
- EBITDA Margin for Q1 2024 stood at 101437.5%, down from 3801.18% in the prior quarter.
- The five-year high for EBITDA Margin was 57.67% in Q3 2022, with the low at 101437.5% in Q1 2024.
- The 3-year median for EBITDA Margin is 1886.3% (2022), against an average of 26288.11%.
- Peak annual rise in EBITDA Margin reached 9763632 bps in 2024, while the deepest fall reached 9763632 bps in 2024.
- Genelux's EBITDA Margin stood at 28.57% in 2022, then sank by 13405 bps to 3801.18% in 2023, then slumped by 2569 bps to 101437.5% in 2024.
- Business Quant data shows GNLX's EBITDA Margin at 101437.5% in Q1 2024, 3801.18% in Q1 2023, and 28.57% in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.75% |
| 10 | Genelux | 120.09 Mn | 120.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -101,437.50% |
| Mar 31, 2023 | -3,801.18% |
| Dec 31, 2022 | 28.57% |
| Sep 30, 2022 | 57.67% |